J. Folkman, Angiogenesis in cancer, vascular, rheumatoid and other disease, Nature Medicine, vol.326, issue.1, pp.27-31, 1995.
DOI : 10.1038/359845a0

P. Carmeliet and R. Jain, Angiogenesis in cancer and other diseases, Nature, vol.407, issue.6801, pp.249-257, 2000.
DOI : 10.1038/35025220

P. Carmeliet, Angiogenesis in life, disease and medicine, Nature, vol.Teill II, issue.7070, pp.932-936, 2005.
DOI : 10.1038/nature04478

G. Taraboletti and B. Margosio, Antiangiogenic and antivascular therapy for cancer, Current Opinion in Pharmacology, vol.1, issue.4, pp.378-384, 2001.
DOI : 10.1016/S1471-4892(01)00065-0

G. Tozer, C. Kanthou, and B. Baguley, Disrupting tumour blood vessels, Nature Reviews Cancer, vol.48, issue.8, pp.423-435, 2005.
DOI : 10.1038/sj.bjc.6690416

H. Hurwitz, L. Fehrenbacher, W. Novotny, T. Cartwright, J. Hainsworth et al., Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancer, New England Journal of Medicine, vol.350, issue.23, pp.2335-2342, 2004.
DOI : 10.1056/NEJMoa032691

F. Kabbinavar, J. Schulz, M. Mccleod, T. Patel, J. Hamm et al., Addition of Bevacizumab to Bolus Fluorouracil and Leucovorin in First-Line Metastatic Colorectal Cancer: Results of a Randomized Phase II Trial, Journal of Clinical Oncology, vol.23, issue.16, pp.3697-3705, 2005.
DOI : 10.1200/JCO.2005.05.112

K. Miller, L. Chap, F. Holmes, M. Cobleigh, P. Marcom et al., Randomized Phase III Trial of Capecitabine Compared With Bevacizumab Plus Capecitabine in Patients With Previously Treated Metastatic Breast Cancer, Journal of Clinical Oncology, vol.23, issue.4, pp.792-799, 2005.
DOI : 10.1200/JCO.2005.05.098

Y. Surh, Cancer chemoprevention with dietary phytochemicals, Nature Reviews Cancer, vol.3, issue.10, pp.768-780, 2003.
DOI : 10.1038/nrc1189

M. Lopez-lazaro, Flavonoids as Anticancer Agents: Structure-Activity Relationship Study, Current Medicinal Chemistry-Anti-Cancer Agents, vol.2, issue.6, pp.691-714, 2002.
DOI : 10.2174/1568011023353714

E. Middleton, J. Kandaswami, C. Theoharides, and T. , The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer, Pharmacol Rev, vol.52, pp.673-751, 2000.

B. Havsteen, The biochemistry and medical significance of the flavonoids, Pharmacology & Therapeutics, vol.96, issue.2-3, pp.67-202, 2002.
DOI : 10.1016/S0163-7258(02)00298-X

S. Hill, K. Williams, and J. Denekamp, Vascular collapse after flavone acetic acid: A possible mechanism of its anti-tumour action, European Journal of Cancer and Clinical Oncology, vol.25, issue.10, pp.1419-1424, 1989.
DOI : 10.1016/0277-5379(89)90099-0

H. Lu, D. Chang, B. Baratte, L. Meijer, and U. Schulze-gahmen, Crystal Structure of a Human Cyclin-Dependent Kinase 6 Complex with a Flavonol Inhibitor, Fisetin, Journal of Medicinal Chemistry, vol.48, issue.3, pp.737-743, 2005.
DOI : 10.1021/jm049353p

A. Olaharski, S. Mondrala, and D. Eastmond, Chromosomal malsegregation and micronucleus induction in vitro by the DNA topoisomerase II inhibitor fisetin, Mutation Research/Genetic Toxicology and Environmental Mutagenesis, vol.582, issue.1-2, pp.79-86, 2005.
DOI : 10.1016/j.mrgentox.2005.01.002

A. Constantinou, R. Mehta, C. Runyan, K. Rao, A. Vaughan et al., Flavonoids as DNA Topoisomerase Antagonists and Poisons: Structure-Activity Relationships, Journal of Natural Products, vol.58, issue.2, pp.217-225, 1995.
DOI : 10.1021/np50116a009

J. Jankun, S. Selman, J. Aniola, and E. Skrzypczak-jankun, Nutraceutical inhibitors of urokinase: Potential applications in prostate cancer prevention and treatment, Oncology Reports, vol.16, pp.341-346, 2006.
DOI : 10.3892/or.16.2.341

M. Böhl, S. Tietze, A. Sokoll, S. Madathil, F. Pfennig et al., Flavonoids Affect Actin Functions in Cytoplasm and Nucleus, Biophysical Journal, vol.93, issue.8, pp.2767-2780, 2007.
DOI : 10.1529/biophysj.107.107813

N. Khan, M. Asim, F. Afaq, Z. Abu, and H. Mukhtar, A Novel Dietary Flavonoid Fisetin Inhibits Androgen Receptor Signaling and Tumor Growth in Athymic Nude Mice, Cancer Research, vol.68, issue.20, pp.8555-8563, 2008.
DOI : 10.1158/0008-5472.CAN-08-0240

A. Salmela, J. Pouwels, A. Varis, A. Kukkonen, P. Toivonen et al., Dietary flavonoid fisetin induces a forced exit from mitosis by targeting the mitotic spindle checkpoint, Carcinogenesis, vol.30, issue.6, pp.1032-1040, 2009.
DOI : 10.1093/carcin/bgp101

C. Edgell, C. Mcdonald, and J. Graham, Permanent cell line expressing human factor VIII-related antigen established by hybridization., Proceedings of the National Academy of Sciences, vol.80, issue.12, pp.3734-3737, 1983.
DOI : 10.1073/pnas.80.12.3734

M. Abramoff, P. Magelhaes, and S. Ram, Image processing with ImageJ, Biophotonics International, vol.11, pp.36-42, 2004.

S. Man, G. Bocci, G. Francia, S. Green, S. Jothy et al., Antitumor effects in mice of low-dose (metronomic) cyclophosphamide administered continuously through the drinking water, Cancer Res, vol.62, pp.2731-2735, 2002.

Q. Ding, P. Kestell, B. Baguley, B. Palmer, J. Paxton et al., Potentiation of the antitumour effect of cyclophosphamide in mice by thalidomide, Cancer Chemotherapy and Pharmacology, vol.50, issue.3, pp.186-192, 2002.
DOI : 10.1007/s00280-002-0482-y

B. Siim, A. Lee, S. Shalal-zwain, F. Pruijn, M. Mckeage et al., Marked potentiation of the antitumour activity of chemotherapeutic drugs by the antivascular agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA), Cancer Chemotherapy and Pharmacology, vol.51, issue.1, pp.43-52, 2003.
DOI : 10.1007/s00280-002-0529-0

T. Browder, C. Butterfield, B. Kraling, B. Shi, B. Marshall et al., Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancer, Cancer Res, vol.60, pp.1878-1886, 2000.

B. Kraling, M. Razon, L. Boon, D. Zurakowski, C. Seachord et al., E-selectin is present in proliferating endothelial cells in human hemangiomas, Am J Pathol, vol.148, pp.1181-1191, 1996.

C. Shia, S. Tsai, S. Kuo, Y. Hou, and P. Chao, Metabolism and Pharmacokinetics of 3,3???,4???,7-Tetrahydroxyflavone (Fisetin), 5-Hydroxyflavone, and 7-Hydroxyflavone and Antihemolysis Effects of Fisetin and Its Serum Metabolites, Journal of Agricultural and Food Chemistry, vol.57, issue.1, pp.83-89, 2009.
DOI : 10.1021/jf802378q

S. Fang, Y. Hou, W. Chang, S. Hsiu, P. Chao et al., Morin sulfates/glucuronides exert anti-inflammatory activity on activated macrophages and decreased the incidence of septic shock, Life Sciences, vol.74, issue.6, pp.743-756, 2003.
DOI : 10.1016/j.lfs.2003.07.017

L. Massaad, I. De-waziers, V. Ribrag, J. F. Beaune, P. Morizet et al., Comparison of mouse and human colon tumors with regard to phase I and phase II drug-metabolizing enzyme systems, Cancer Res, vol.52, pp.6567-6575, 1992.

A. Joussen, K. Rohrschneider, J. Reichling, B. Kirchhof, and F. Kruse, Treatment of Corneal Neovascularization with Dietary Isoflavonoids and Flavonoids, Experimental Eye Research, vol.71, issue.5, pp.483-487, 2000.
DOI : 10.1006/exer.2000.0900

Y. Kakeji and B. Teicher, Preclinical studies of the combination of angiogenic inhibitors with cytotoxic agents, Investigational New Drugs, vol.15, issue.1, pp.39-48, 1997.
DOI : 10.1023/A:1005718628223

T. Chou and P. Talalay, Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors, Advances in Enzyme Regulation, vol.22, pp.27-55, 1984.
DOI : 10.1016/0065-2571(84)90007-4

M. Pepper, A. Sappino, R. Stocklin, R. Montesano, L. Orci et al., Upregulation of urokinase receptor expression on migrating endothelial cells, The Journal of Cell Biology, vol.122, issue.3, pp.673-684, 1993.
DOI : 10.1083/jcb.122.3.673